Introduction {#s0001}
============

About 60--70% of all men with lower urinary tract symptoms (LUTS) consult their general practitioner (GP).[@cit0001] Initially, a GP may provide education about the benign nature of their symptoms and offer non-medical and medical treatments, such as alpha-blockers.[@cit0002]--[@cit0004] In the primary care setting, generally, no additional testing is applied, and treatment involves a trial and error approach, especially with alpha-blockers.[@cit0002] If these treatments are ineffective, however, the GP may consider referring men to urologists for additional investigation and treatment. This may include not only prescribing other drugs but also performing invasive treatments, such as transurethral resection of the prostate.[@cit0005],[@cit0006]

Patient opinions and expectations are important when deciding on treatment options, with evidence in other fields suggesting that patient-centered care is associated with improved outcomes and satisfaction.[@cit0007] Notably, higher treatment expectations result in better treatment outcomes,[@cit0008],[@cit0009] and their fulfilment leads to greater treatment satisfaction.[@cit0009] Certain patient characteristics influence these expectations.[@cit0010] Unfortunately, when expectations are unrealistically high and cannot be met, the result may be decreased satisfaction or dissatisfaction.[@cit0011] Although these data indicate the benefits of knowing a patient's expectations, we are unaware of any studies describing expectations among male patients with LUTS. This is an important knowledge gap because such information may help urologists gain a better understanding of the needs of these patients to enable them to deliver more tailored care.

In this study, we aim to identify the expectations of men with LUTS who are referred to a urologist. To further our understanding, we then studied the association between patient expectations and satisfaction related to the care of a urologist.

Patients and Methods {#s0002}
====================

Study Design and Participants {#s0002-s2001}
-----------------------------

We conducted a prospective cohort study into the effects of an online self-management program, as has been described elsewhere.[@cit0012] Participants were recruited through the urology outpatient departments of three large teaching hospitals in the Netherlands between April 2017 and March 2018. We included men older than 18 who were referred for the first time with LUTS, who had no history of acute urinary retention, recurrent urinary tract infections, or known prostate, or bladder abnormalities. In general, based only on symptoms, no diagnose can be put in order. So, we follow the International Continence Society definitions of symptoms, and use the term LUTS. The cohort study consisted of two parts. In the first period, all men received care as usual, in the second period, men also received access to an online self-management program, after their first outpatient clinic consultation. The baseline assessment and follow-up questionnaires in this cohort study were the same for both periods of patient recruitment.[@cit0012]

Invitations were by post before their first consultation. Men were not invited if it was clear from their referral letter that they had (1) a history of prostate or bladder cancer, (2) previous lower urinary tract surgery, (3) neurogenic bladder or (4) an indication for acute intervention (eg, urinary retention).

Information was provided to patients in a letter and a video message. A member of the research team met with candidate participants 20--30 minutes before their appointment with the urologist. During this meeting, eligibility criteria were checked, and we excluded any men who were unable to understand Dutch. Participants were given an opportunity to ask questions, before being asked to sign the informed consent form and to turn in the baseline questionnaire. Men were excluded from follow-up if the assessment by the urologist suggested that they may have bladder cancer, prostate cancer, urethral stricture or neurogenic bladder. Two concurrent recruitment phases were used in each hospital. Participants in the first phase received care as usual, whereas participants in the second phase received care as usual plus access to an online self-management program.

Data Collection {#s0002-s2002}
---------------

Data collection was by three questionnaires: one before their first appointment with the urologist, one 6 weeks later and one 12 weeks later.

In the baseline questionnaire, we inventoried patient characteristics, symptom severity and patient expectations. We measured symptom severity by the international prostate symptom score (IPSS),[@cit0013] and the overactive bladder questionnaire -- short form (OAB-q SF).[@cit0014] Expectations were categorized as follows: (1) expectations of the general care of the urologist with 4 questions, (2) expectations of the treatment plan with 4 questions and (3) expectations of the treatment outcomes with 6 questions. For each question, we used a 5-point Likert scale ranging from "very unlikely" to "very likely". In the absence of validated questionnaires for this purpose, we used a self-constructed, non-validated questionnaire (see [[Supplementary file 1](https://www.dovepress.com/get_supplementary_file.php?f=264994-supplement-1.docx)]{.ul} for the questions on expectations).

At 6 weeks, the IPSS and OAB-q-SF were repeated and we obtained information on the received treatment, consistency with prior expectations and satisfaction with treatment. Consistency with expectations and satisfaction were rated on 5-point Likert scales, ranging from "strongly disagree" to "strongly agree". At 12 weeks, the treatment received and the satisfaction with that treatment were again assessed, but using a 7-point Likert-type scale (ranging from "absolutely satisfied" to "absolutely not satisfied"). The IPSS and OABq-SF were also repeated, and the Perceived Global Impression of Improvement (PGI-I) was added.[@cit0015]

Follow-up questionnaires were sent according to participant preference by e-mail or post. Participants who did not return the follow-up questionnaire within 2 weeks received a reminder. If participants did not respond, no further reminders were sent. However, non-responders after 6 weeks still received the follow-up questionnaire at 12 weeks.

Outcome Measures {#s0002-s2003}
----------------

The primary outcome measure was the patient expectations at baseline. Secondary outcome measures were treatment satisfaction and the association between expectations and chosen therapy after 6 weeks.

Statistical Analyses {#s0002-s2004}
--------------------

We performed all analyses with IBM SPSS version 25 (IBM Corp., Armonk, NY, USA), using the full data set. Missing values were not imputed, and we considered a p-value of 0.05 or smaller to be statistically significant in all analyses. The expectations of patients are displayed as frequencies and percentages.

Patient Expectations at Baseline {#s0002-s2005}
--------------------------------

Answers on the 5-point Likert scale were grouped as positive expectations ("very likely" and "likely"), neutral expectations ("neutral") and negative expectations ("unlikely" and "very unlikely"). For analysis, the neutral expectations group was combined with the negative expectations group. This was an arbitrary choice, for which no firm rationale is present. We then explored the expectations toward active treatment options (physiotherapy, medication and surgery) by testing if expectations differed by age group, symptom severity and expected treatment outcomes, using multivariable logistic regression analyses. Nagelkerke R^2^ was used to show the percentage of explained variance for the model.

Agreement Between Expected and Actual Treatment {#s0002-s2006}
-----------------------------------------------

The characteristics of responders and non-responders were checked for imbalances in age, body mass index, education level and baseline IPSS score. For these analyses, we excluded all men who appeared to have prostate or bladder cancer after the outpatient assessment.

Agreement between the received and expected treatments at 6 weeks was defined in two ways. First, we defined "objective agreement" based on the reported expectations at baseline and categorized participants into "expectations met" and "expectations unmet" groups (eg, if at baseline a participant expressed the expectation to receive drug therapy, and after 6 weeks reported to have received drug therapy, the expectations were met). Second, we defined "subjective agreement" based on response to whether treatment was deemed consistent with initial expectations (asked in the second questionnaire at 6 weeks), dividing responders into an agreement group ("agree" and "strongly agree") and a non-agreement group (all other responses). We then compared both measures of agreement. For each measure of agreement, we tested the difference in satisfaction between groups using the Mann--Whitney *U*-test.

Treatment Outcomes {#s0002-s2007}
------------------

We also explored if agreement between expected and actual treatment improved outcomes. First, we used the change in IPSS from the baseline to the follow-up questionnaire (ie, delta-IPSS). The delta-IPSS was then compared for both measures of agreement by independent sample *t*-tests. Second, we dichotomized the PGI-I score, as completed at 12 weeks, into clear improvement ("much better" and "very much better") and no clear improvement (all other responses). These categories were compared for both measures of agreement by chi-square tests. Given that measures of agreement were assessed at 6 weeks, we added a post-hoc analysis for the subgroup of men with no change in treatment between 6 and 12 weeks.

Patient Satisfaction {#s0002-s2008}
--------------------

Finally, we explored the predictors of positive patient satisfaction with the provided care at both 6 and 12 weeks. For this, we dichotomized responses to the statement "I am satisfied with the treatment provided by the urologist" after 6 weeks into satisfied ("agree" or "definitely agree") or dissatisfied (all other responses). For data at 12 weeks, we combined "absolutely satisfied", "very satisfied" and "somewhat satisfied" into a satisfied category and all other responses into a dissatisfied category. Logistic regression analyses were then performed, using patient satisfaction as the dependent variable. We added age, delta-IPSS, subjective agreement and objective agreement as independent variables. The Nagelkerke R^2^ was used to present the percentage of explained variance of the multivariable model.

Results {#s0003}
=======

In total, 187 of the 349 (54%) invited men agreed to participate. Another 5 participants were excluded because they had either already undergone surgery for BPH (n = 1) or they had complete (n = 2) or partial (n = 2) missing data at baseline. The remaining 182 participants constitute the baseline cohort for which characteristics are presented in [Table 1](#t0001){ref-type="table"}. A flow chart for study inclusion is presented in [[Supplementary File 2](https://www.dovepress.com/get_supplementary_file.php?f=264994-supplement-2.pdf)]{.ul}.Table 1Baseline Characteristics of 182 Men Referred to Secondary CareAgeMean (SD)64.6 (12.3)Categories, % (n)\<509.9% (18)50--7047.8% (87)\>7042.3% (77)**Body mass index**\*Median \| IQR26.1 \| 4.9Categories, % (n)\<2535.7% (65)25--3048.4% (88)\>3015.4% (28)**Education**, % (n)None or elementary9.9% (18)Lower education28.6% (52)Secondary education24.7% (45)Higher education36.8% (67)**IPSS**Mean score (sd)18.8 (6.3)Categories, % (n)Mild (0--7)4.4% (8)Moderate (8--19)51.6% (94)Severe (\>19)44.0% (80)**IPSS QoL**Median \| IQR4 \| 2**OABq-SF**Median \| IQR40 \| 26.7**Co-morbidity**, % (n)None56.6% (103)Yes, one or more43.4% (79)Specified, % (n)Cardiovascular diseases24.2% (44)Diabetes Mellitus14.8% (27)Chronic obstructive pulmonary disease7.7% (14)Sleep apnea11.5% (21)Cerebrovascular accident4.4% (8)Parkinson's disease0.5% (1)[^1][^2]

Patient Expectations {#s0003-s2001}
--------------------

The expectations of participants at the baseline assessment are summarized in [Figure 1](#f0001){ref-type="fig"}. Most patients were positive about the urologist performing examinations (90%), providing an explanation about the cause of their symptoms (97%), finding the underlying cause of their symptoms (83%) and collaborating in the forming of a treatment plan (88%). Concerning the treatment plans themselves, 41.2--46.7% of participants had neutral expectations. However, participants had positive expectations of lifestyle advice (51%) and drug treatments (43%), but negative expectations of physiotherapy (43%) and surgery (33%).Figure 1Patient expectations of outpatient care provided by urologists. The figure shows the proportion of participants with negative (red), neutral (yellow) and positive (green) expectations.

Many men (39.0--52.7%) had neutral expectations about the ability of treatments to reduce symptoms, while drug treatment (43.4%) and surgery (30.8%) were associated with the most positive expectations, and physiotherapy (50.5%) was associated with the most negative expectations. Expectations about reducing complaints with lifestyle advice were divided, with 27.5%, 51.1% and 21.4% expressing negative, neutral and positive expectations, respectively. Concerning adverse effects, participants had neutral expectations of drug treatment (52.7%) and surgery (61.0%).

As shown in [Table 2](#t0002){ref-type="table"}, positive expectations about treatment were clearly associated with positive expectations about outcomes. Higher symptom scores were associated with expectations about drug treatment, but not with expectations about surgery and physiotherapy. Age was associated with treatment expectations only for drug treatment (Nagelkerke R^2^ 0.38).Table 2Associations Between Positive Expectations About Receiving a Treatment and the Age, Symptoms Severity and Expectation of Receiving a Specific TreatmentNumber of Men IncludedPhysiotherapyDrug TreatmentSurgeryN = 182N = 182N = 182Age in decades1.32 (0.86--2.03)1.39 (1.02--1.89)1.32 (0.86--2.02)Symptom severity1.04 (0.95--1.12)1.10 (1.04--1.17)1.08 (0.995--1.18)Positive expectation towards treatment outcome4.11 (1.93--8.72)4.47 (2.66--7.50)11.70 (4.97--29.14)% of explained variance\*0.220.380.50[^3]

Agreement Between Expected and Actual Treatment {#s0003-s2002}
-----------------------------------------------

We excluded 17 men who appeared to have urethral strictures, prostate cancer or bladder cancer. Another 21 and 20 participants were lost to follow-up at 6 and 12 weeks, respectively. The non-responders at 6 weeks were significantly younger than the responders (57.8 ± 12.2 vs 65.2 ± 12.5 years; t = −2.540, p = 0.012), but other characteristics did not differ. This pattern was repeated at 12 weeks, with non-responders again being significant younger (59.0 ± 16.3 vs 66.2 ± 11.5 years; t = - 2.434, p = 0.016). In the remaining 144 participants at 6 weeks, objective agreement was noted between expected and actual treatment in 27.8% of cases, whereas subjective agreement was noted in 66.0%. There was agreement between subjective and objective agreement in only 22 cases ([Table 3](#t0003){ref-type="table"}).Table 3Comparison of Subjective and Objective Agreement Between Expected and Actual Treatment at 6 WeeksSubjectiveAgreementNo Agreement**Objective**Agreement2217No agreement7331

Treatment Outcomes {#s0003-s2003}
------------------

Overall, 29 of 123 participants (23.6%) at 12 weeks reported clear improvement. Subjective improvement (PGI-I) did not differ between men with either objective agreement (*χ*^2^ = 0.218, p = 0.813) or subjective agreement (*χ*^2^ = 0.038, p = 1.000). Post-hoc analysis gave the same results when including only participants with no treatment change (objective agreement: *χ*^2^ = 0.002, p = 1.000; subjective agreement: *χ*^2^ = 0.022, p = 1.000). The IPSS decreased on average by −3.41 ± 5.53 points after 6 weeks and −4.34 ± 5.99 points after 12 weeks. At 6 weeks, the delta-IPSS was significantly higher when expectations were objectively met (mean decrease, −5.0 ± 5.8 points) than when they were not objectively met (mean decrease, −2.8 ± 5.3 points; t = 2.202, p = 0.029). For the subjective agreement categories, no significant difference was found between the agreement and non-agreement groups (−2.9 ± 5.5 vs −4.4 ± 5.6; t = −1.596, p = 0.113). At 12 weeks there was also no difference in delta-IPSS between the agreement and non-agreement groups for either objective or subjective agreement. This did not change with the post-hoc analysis for participants without a change in treatment.

Patient Satisfaction {#s0003-s2004}
--------------------

At 6 weeks, most men were satisfied (56.4%) or very satisfied (21.8%) with the care received from the urologist. It was notable that objectively meeting or not meeting patient expectations did not affect patient satisfaction (odds ratio \[OR\] 2.28, 95% CI 0.74--7.05). By contrast, subjective fulfilment was associated with significantly greater satisfaction with a urologist's care than when subjective fulfilment was lacking (OR 35.63, 95% CI 11.91--106.62).

At 12 weeks, most men (71.5%) remained satisfied with the care of their urologist. Again, objectively meeting or not meeting expectations did not affect satisfaction (OR 0.50, 95% CI 0.20--1.28), whereas subjective fulfilment still led to increased satisfaction (OR 4.81, 95% CI 2.01--11.49). Post-hoc analysis of patients with no treatment change at 12 weeks yielded a positive, but statistically non-significant, association for subjective fulfilment only (OR 2.92 95% CI 0.97--8.80) ([Table 4](#t0004){ref-type="table"}). Change in the IPSS was significantly associated with satisfaction (OR 0.92, 95% CI 0.84--1.00).Table 4Associations of Treatment Satisfaction with Age, Change in Symptom Severity, Objective Agreement and Subjective AgreementNumber of Men Included6 Weeks12 Weeks12 Weeks\*N = 143\*\*N = 123\*\*N = 78Age in decades0.84 (0.57--1.23)1.04 (0.72--1.51)1.15 (0.74--1.78)Delta-IPSS0.94 (0.85--1.04)0.92 (0.84--1.00)0.91 (0.82--1.01)Objective agreement2.28 (0.74--7.05)0.50 (0.20--1.28)0.44 (0.14--1.40)Subjective agreement35.63 (11.91--106.62)4.81 (2.01--11.49)2.92 (0.97--8.80)% of explained variance0.500.200.14[^4][^5]

Discussion {#s0004}
==========

We primarily aimed to identify the expectations of men with LUTS who were referred to a urologist. This is a diverse patient group consisting of men with LUTS due to different causes, such as benign prostate enlargement, or overactive bladder. Most patients expected a urologist to perform examinations, to provide an explanation and to find the underlying cause of their symptoms. They also expected to be involved in treatment choices, mainly for drug therapy, and not for physiotherapy. Higher expectations for treatment outcomes resulted in higher expectations when receiving the treatment. Furthermore, a higher symptom severity score was associated with higher expectations for medication or surgery. Finally, we showed that men who reported that their expectations were fulfilled were more likely to be satisfied with the care given by the urologist. This satisfaction was not affected by objective agreement between the expected and actual treatments. By contrast, subjective agreement led to higher satisfaction.

The existing guideline on male LUTS for Dutch GPs only briefly mentions the possible reasons for referring men with LUTS.[@cit0002] Limited communication with patients before referral may have led to the high percentage of patients with neutral expectations for each treatment option in this study. Lack of information from the hospital may also result in non-specific expectations before the first outpatient department visit. GPs and urologists need to make arrangements on how to inform patients about what they can expect from a referral.

We encountered a large discrepancy between the fulfilment of expectations in the objective and subjective assessments. Most patients who reported that the treatment they received satisfied their expectations did not expect that treatment. This might reflect that patients could not remember what they expected 6 weeks ago. In the group with neutral expectations, one might anticipate this result given that baseline expectations were equivocal. It could also be that patients considered not only the received treatment but also the consultation experience with the urologist. This may explain why patients who reported subjective fulfilment were more satisfied with the care given by the urologist than patients who reported objective fulfilment.

We could find no other studies concerning patient expectations before referral to urology services. By contrast, research in orthopedics services has already established that patient satisfaction is higher when expectations are fulfilled.[@cit0009],[@cit0016]--[@cit0018] However, these studies looked at the fulfilment of preoperative expectations on postoperative outcomes. We showed that patients are also more satisfied with care when they think that they received the treatment they expected. This supports the position that clinicians should consider patient preferences and act to achieve those whenever possible and appropriate.

Other studies have shown that greater expectations of a given treatment result in better patient-reported outcomes. For example, Flood et al showed that patients undergoing transurethral resection of the prostate who had positive expectations preoperatively reported greater improvement.[@cit0019] In addition, Jain et al found that higher preoperative expectations in patients undergoing total knee arthroplasty predicted greater improvements in patient-reported outcomes.[@cit0009] Consistent with these results, we also showed that treatment outcomes were better when patients receive the treatments they expect. Interestingly, however, treatment outcomes were poorer when patients self-reported that a treatment met their expectations.

A limitation of this study was the use of a non-validated questionnaire to assess patient expectations, which exemplifies an underlying issue that most validated questionnaires only detail patient-reported outcomes and not their expectations. The sample size was also small, especially in some of the subgroup analyses, which resulted in wide confidence intervals and several outcomes that should be interpreted with caution. Still, despite this issue, the percentage of explained variance for most analyses was considerable, showing that most of the relevant characteristics will have been considered.

We conclude that it is important for both GPs and urology outpatient departments to provide better information to men with LUTS, thereby granting patients the opportunity to consider different treatment options and to have better informed expectations. This may result in higher levels of satisfaction with the care given by urologists.
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[^1]: **Note:** \*One person had no information on BMI.

[^2]: **Abbreviations:** IPSS, international prostate symptom score; OABq-SF, overactive bladder questionnaire -- short form; QoL, quality of life.

[^3]: **Notes:** Data are the odds ratio and 95% confidence intervals from logistic regression analyses. \*Nagelkerke R^2^-test for multivariable models.

[^4]: **Notes:** Data resulted from logistic regression analyses and reflect odds ratios with 95% confidence intervals. \*Post-hoc analysis including only participants without treatment change between 6 weeks and 12 weeks of follow-up. \*\*One of the 144 participants had missing data on the outcome. It was another participant for 6 and 12 weeks.

[^5]: **Abbreviation:** IPSS, international prostate symptom score.
